The global health pandemic of COVID-19 has upended seemingly everything, from the way commerce is conducted to the ways we interact with one another (or don’t interact with one another). But enforcement involving pharmaceutical and medical device manufacturers has remained relatively steady. As we move out of the initial phase of the pandemic and as healthcare becomes an even more critical part of the national and international infrastructure, concerns about fraud and abuse mount with the added pressure to develop treatments, equipment, and a vaccine. This presentation will dig into recent DOJ statements, settlement announcements, and pending enforcement activity to update attendees on what we’re seeing in this new abnormal world.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, email@example.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.
General information on our practice is available in our electronic publications Serving the Life Sciences Industry and Serving the Healthcare Industry. If you would like to be included on our regular pharmaceutical manufacturers, medical device manufacturers or healthcare provider mailing lists to receive notices of other events and written updates, you can be added by submitting your full contact information to firstname.lastname@example.org and specifying the list you wish to join.